BioPharma Credit PLC (LON:BPCR)
London · Delayed Price · Currency is GBP · Price in USD 0.9660
-0.0140 (-1.43%)
Oct 8, 2026, 4:35 PM GMT
BioPharma Credit Earnings Call Transcripts
Fiscal Year 2026
-
Share price rose to $0.97, reducing buybacks, while net income per share for H1 2026 was just under $0.045, lower than last year due to fewer prepayments and no large one-time settlements. The portfolio is highly diversified, with new loans to Kestra, Idorsia, Mineralys, and Esperion, and the only historical default fully recovered.